Sign InCreate AccountAbout Bosscoin
ExploreHelpBossUp Program

 Trending Investment Ideas Latest Guru Posts
SONN
Sonnet BioTherapeutics Holdings Inc
Market Cap
$5,042,090.00
52 Week High
$26.40
PE Ratio
-
52 Week Low
$1.08
EPS
-
Shares Outstanding
3,112,401.00
Dividend Yield
-
Dividend Per Share
-
PoweredByInsightfulIR
SONN - Top Posts
Image
Muhammad

General 09/25/2022

SONN, Buy

Sonnet BioTherap...
Return: 241.06%

SONN, Buy

Sonnet BioTherapeutics Holdings Inc
Return: 241.06%
Sonnet Biotherapeutics Holding Inc. | Sonn Stock Analysis

A company called Sonnet Biotherapeutics has been developing a drug that treats inflammatory bowel disease known as Crohn's.

 |  |  
Small Cap Feed
|  
Dividend Growth Stock
|  
ESG Stock
|  
Great Products
|  
Lifestyle Investing
|  
Consumer Discretionary Feed
|  
Was Trending
Image
John

Florida 12/17/2020

SONN, Buy

Sonnet BioTherap...

SONN, Buy

Sonnet BioTherapeutics Holdings Inc

 |  
Consumer Discretionary Feed
Image
John

Florida 02/18/2021

SONN, Closed

Sonnet BioTherap...

SONN, Closed

Sonnet BioTherapeutics Holdings Inc
**POSITION UPDATE**

 |  
Consumer Discretionary Feed
Image
John

Florida 02/18/2021

SONN, Big Buy

Sonnet BioTherap...
Return: -87.66%

SONN, Big Buy

Sonnet BioTherapeutics Holdings Inc
Return: -87.66%

 |  
Bullish Feed
|  
Consumer Discretionary Feed
Latest News